COIOSDeep risk insights through multi-disciplinary research across the globe
a clock on a pole in a town square
Item refines Preprint · not peer-reviewed Added

Seven in ten US women stay on endocrine therapy for one year

Of 401,450 US women starting adjuvant endocrine therapy after breast surgery, 69.9% had a medication possession ratio of at least 80% over the first year.

Claims records for 401,450 US women who began tamoxifen or an aromatase inhibitor after breast surgery were linked to commercial scores estimating attitudes and circumstances. Of these women, 69.9% had a medication possession ratio of 80% or more over the first 365 days. After adjustment for clinical and demographic factors, comfort following medication instructions and proximity to a breast oncologist carried adjusted odds ratios of 1.15 and 1.17.

Why it is interesting: A national first-year adherence figure for a therapy whose benefit depends on five to ten years of daily use.

Source
medRxiv, 26 September 2026
Paper
Behavioral profiles associated with adherence to adjuvant endocrine therapy in breast cancer: a retrospective population-based cohort study
Authors
Dibner-Dunlap A, Sutermaster S, Smittenaar P, Sgaier S
DOI
10.64898/2026.05.25.26353903
Type
Preprint
Design
Retrospective cohort, 401,450 US women with invasive breast cancer initiating oral endocrine therapy 2016-2025, claims linked to modelled behavioural scores
Verdict
Refines prior evidence
Driver
Adherence and persistence
Driver
Cancer
Driver
What linked data reveals

Other drivers in Behavioural science